1. Home
  2. DCTH vs PANL Comparison

DCTH vs PANL Comparison

Compare DCTH & PANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • PANL
  • Stock Information
  • Founded
  • DCTH 1988
  • PANL 1996
  • Country
  • DCTH United States
  • PANL United States
  • Employees
  • DCTH N/A
  • PANL N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • PANL Marine Transportation
  • Sector
  • DCTH Health Care
  • PANL Consumer Discretionary
  • Exchange
  • DCTH Nasdaq
  • PANL Nasdaq
  • Market Cap
  • DCTH 379.8M
  • PANL 289.9M
  • IPO Year
  • DCTH N/A
  • PANL N/A
  • Fundamental
  • Price
  • DCTH $12.64
  • PANL $5.76
  • Analyst Decision
  • DCTH Strong Buy
  • PANL Strong Buy
  • Analyst Count
  • DCTH 4
  • PANL 1
  • Target Price
  • DCTH $21.50
  • PANL N/A
  • AVG Volume (30 Days)
  • DCTH 473.2K
  • PANL 202.4K
  • Earning Date
  • DCTH 11-08-2024
  • PANL 11-12-2024
  • Dividend Yield
  • DCTH N/A
  • PANL 6.96%
  • EPS Growth
  • DCTH N/A
  • PANL N/A
  • EPS
  • DCTH N/A
  • PANL 0.47
  • Revenue
  • DCTH $22,644,000.00
  • PANL $521,238,386.00
  • Revenue This Year
  • DCTH $1,605.13
  • PANL $8.04
  • Revenue Next Year
  • DCTH $111.67
  • PANL $13.05
  • P/E Ratio
  • DCTH N/A
  • PANL $12.19
  • Revenue Growth
  • DCTH 945.91
  • PANL 5.23
  • 52 Week Low
  • DCTH $2.60
  • PANL $5.43
  • 52 Week High
  • DCTH $12.88
  • PANL $9.53
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 73.89
  • PANL 38.27
  • Support Level
  • DCTH $9.33
  • PANL $5.77
  • Resistance Level
  • DCTH $10.04
  • PANL $5.85
  • Average True Range (ATR)
  • DCTH 0.61
  • PANL 0.22
  • MACD
  • DCTH 0.25
  • PANL -0.05
  • Stochastic Oscillator
  • DCTH 96.17
  • PANL 24.09

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

About PANL Pangaea Logistics Solutions Ltd.

Pangaea Logistics Solutions Ltd and its subsidiaries provide seaborne drybulk transportation services. It transports drybulk cargos including grains, coal, iron, ore, pig, iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The firm's services include cargo loading, cargo discharge, vessel chartering, voyage planning and technical vessel management. The company derives all of its revenues from contracts of affreightment, voyage charters and time charters.

Share on Social Networks: